Product NDC: | 10267-2529 |
Proprietary Name: | Broncho Dilate |
Non Proprietary Name: | Ephedrine HCl Guaifenesin |
Active Ingredient(s): | 12.5; 200 mg/1; mg/1 & nbsp; Ephedrine HCl Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10267-2529 |
Labeler Name: | Contract Pharmacal Corp |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20020213 |
Package NDC: | 10267-2529-7 |
Package Description: | 4 BLISTER PACK in 1 CARTON (10267-2529-7) > 15 TABLET in 1 BLISTER PACK |
NDC Code | 10267-2529-7 |
Proprietary Name | Broncho Dilate |
Package Description | 4 BLISTER PACK in 1 CARTON (10267-2529-7) > 15 TABLET in 1 BLISTER PACK |
Product NDC | 10267-2529 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ephedrine HCl Guaifenesin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20020213 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Contract Pharmacal Corp |
Substance Name | EPHEDRINE HYDROCHLORIDE; GUAIFENESIN |
Strength Number | 12.5; 200 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |